Terveystalo PLC (FRA:4TS)
€ 7.65 +0.23 (+3.1%) Market Cap: 982.77 Mil Enterprise Value: 1.54 Bil PE Ratio: 14.90 PB Ratio: 1.92 GF Score: 73/100

Q1 2025 Terveystalo Oyj Earnings Call Transcript

Apr 25, 2025 / 07:30AM GMT
Release Date Price: €11.4 (-1.04%)

Key Points

Positve
  • Terveystalo PLC (FRA:4TS) reported a 20% increase in adjusted EBITDA and a 40% rise in EPS, indicating strong profitability improvements.
  • Customer satisfaction, as measured by the NPS, continues to trend upwards, reflecting positive client experiences.
  • The healthcare services segment showed a healthy demand growth of nearly 5%, despite one less working day compared to the previous quarter.
  • The company has been successful in improving operational efficiency and service mix, contributing to robust financial results.
  • Terveystalo PLC (FRA:4TS) maintains a strong balance sheet with a net debt to EBITDA ratio of 2.2%, providing financial stability and capacity for future investments.
Negative
  • Revenue was slightly down due to softness in the Swedish market and discontinued outsourcing contracts.
  • The publicly funded market remains cautious, impacting the staffing segment and contributing to revenue decline.
  • The Swedish economy's slow recovery and global economic turmoil present challenging market conditions.
  • The company faces potential indirect impacts from global economic uncertainties, such as tariffs and employment level changes.
  • Cash flow showed a slow start for the year, partly due to tax impacts and timing differences, creating volatility.
Juuso Pajunen
Terveystalo Oyj - Chief Financial Officer, Member of the Management Group

Good morning everybody and welcome to Terveystalo's first quarter results, webcast and conference call. My name is Kati Kaksonen. I am responsible for Terveystalo investor relations and sustainability.

As usual, our CEO Ville Iho and our CFO Juuso Pajunen will present the results and we will follow that with the Q&A. We will take questions from the phone lines as well as through the webcast and from the audience if there is any. But without further delay, over to you.

Ville Iho
Terveystalo Oyj - President, Chief Executive Officer, Member of the Management Group

thank you Kati diving into Q1 very shortly through the key numbers, all in all solid start of the year and continuing on improvement path that we have laid out during the last two years. Margin is up our adjusted EBITDA is up by 20%, EPS are up by 40% against slightly dropping revenue line.

Which is then again due to softness in Sweden, softness in portfolios, and some discontinued

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot